[42]
Arena, C.; Troiano, G.; Zhurakivska, K.; Nocini, R.; Muzio, L. Stomatitis and EGFR-tyrosine kinase inhibitors: a review of current literature in 4353 patients. Clin. Oncol. (R. Coll. Radiol.), 2018, 3, 1549-1555.
[52]
Hillier, L.W.; Fulton, R.S.; Fulton, L.A.; Graves, T.A.; Pepin, K.H.; Wagner-McPherson, C.; Layman, D.; Maas, J.; Jaeger, S.; Walker, R.; Wylie, K.; Sekhon, M.; Becker, M.C.; O’Laughlin, M.D.; Schaller, M.E.; Fewell, G.A.; Delehaunty, K.D.; Miner, T.L.; Nash, W.E.; Cordes, M.; Du, H.; Sun, H.; Edwards, J.; Bradshaw-Cordum, H.; Ali, J.; Andrews, S.; Isak, A.; Vanbrunt, A.; Nguyen, C.; Du, F.; Lamar, B.; Courtney, L.; Kalicki, J.; Ozersky, P.; Bielicki, L.; Scott, K.; Holmes, A.; Harkins, R.; Harris, A.; Strong, C.M.; Hou, S.; Tomlinson, C.; Dauphin-Kohlberg, S.; Kozlowicz-Reilly, A.; Leonard, S.; Rohlfing, T.; Rock, S.M.; Tin-Wollam, A.M.; Abbott, A.; Minx, P.; Maupin, R.; Strowmatt, C.; Latreille, P.; Miller, N.; Johnson, D.; Murray, J.; Woessner, J.P.; Wendl, M.C.; Yang, S.P.; Schultz, B.R.; Wallis, J.W.; Spieth, J.; Bieri, T.A.; Nelson, J.O.; Berkowicz, N.; Wohldmann, P.E.; Cook, L.L.; Hickenbotham, M.T.; Eldred, J.; Williams, D.; Bedell, J.A.; Mardis, E.R.; Clifton, S.W.; Chissoe, S.L.; Marra, M.A.; Raymond, C.; Haugen, E.; Gillett, W.; Zhou, Y.; James, R.; Phelps, K.; Iadanoto, S.; Bubb, K.; Simms, E.; Levy, R.; Clendenning, J.; Kaul, R.; Kent, W.J.; Furey, T.S.; Baertsch, R.A.; Brent, M.R.; Keibler, E.; Flicek, P.; Bork, P.; Suyama, M.; Bailey, J.A.; Portnoy, M.E.; Torrents, D.; Chinwalla, A.T.; Gish, W.R.; Eddy, S.R.; McPherson, J.D.; Olson, M.V.; Eichler, E.E.; Green, E.D.; Waterston, R.H.; Wilson, R.K. The DNA sequence of human chromosome 7.
Nature, 2003,
424(6945), 157-164.
[
http://dx.doi.org/10.1038/nature01782] [PMID:
12853948]
[53]
O’Leary, N.A.; Wright, M.W.; Brister, J.R.; Ciufo, S.; Haddad, D.; McVeigh, R.; Rajput, B.; Robbertse, B.; Smith-White, B.; Ako-Adjei, D.; Astashyn, A.; Badretdin, A.; Bao, Y.; Blinkova, O.; Brover, V.; Chetvernin, V.; Choi, J.; Cox, E.; Ermolaeva, O.; Farrell, C.M.; Goldfarb, T.; Gupta, T.; Haft, D.; Hatcher, E.; Hlavina, W.; Joardar, V.S.; Kodali, V.K.; Li, W.; Maglott, D.; Masterson, P.; McGarvey, K.M.; Murphy, M.R.; O’Neill, K.; Pujar, S.; Rangwala, S.H.; Rausch, D.; Riddick, L.D.; Schoch, C.; Shkeda, A.; Storz, S.S.; Sun, H.; Thibaud-Nissen, F.; Tolstoy, I.; Tully, R.E.; Vatsan, A.R.; Wallin, C.; Webb, D.; Wu, W.; Landrum, M.J.; Kimchi, A.; Tatusova, T.; DiCuccio, M.; Kitts, P.; Murphy, T.D.; Pruitt, K.D. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation.
Nucleic Acids Res., 2016,
44(D1), D733-D745.
[
http://dx.doi.org/10.1093/nar/gkv1189] [PMID:
26553804]
[89]
Jensen, L. J.; Kuhn, M.; Stark, M.; Chaffron, S.; Creevey, C.; Muller, J.; Doerks, T.; Julien, P.; Roth, A.; Simonovic, M. STRING
8—a global view on proteins and their functional interactions in 630
organisms. Nucleic Acids Res., 2008, 37(suppl_1), D412-D416.
[90]
Chatr-Aryamontri, A.; Ceol, A.; Palazzi, L. M.; Nardelli, G.; Schneider, M. V.; Castagnoli, L.; Cesareni, G. MINT: the
Molecular INTeraction database. Nucleic Acids Res., 2006, 35(suppl_1), D572-D574.
[91]
Mishra, G. R.; Suresh, M.; Kumaran, K.; Kannabiran, N.; Suresh, S.; Bala, P.; Shivakumar, K.; Anuradha, N.; Reddy, R.; Raghavan, T. M. Human protein reference database—2006 update. Nucleic Acids Res., 2006, 34(suppl_1), D411-D414.
[92]
Alfarano, C.; Andrade, C.; Anthony, K.; Bahroos, N.; Bajec, M.; Bantoft, K.; Betel, D.; Bobechko, B.; Boutilier, K.; Burgess, E. The biomolecular interaction network database and related tools 2005 update. Nucleic Acids Res.,, 2005, 33(suppl_1), D418-D424.
[93]
Salwinski, L.; Miller, C. S.; Smith, A. J.; Pettit, F. K.; Bowie, J. U.; Eisenberg, D. The database of interacting proteins: 2004 update. Nucleic Acids Res., 2004, 32(suppl_1), D449-D451.
[94]
Breitkreutz, B.-J.; Stark, C.; Reguly, T.; Boucher, L.; Breitkreutz, A.; Livstone, M.; Oughtred, R.; Lackner, D. H.; Bähler, J.; Wood, V. The BioGRID interaction database: 2008 update. Nucleic Acids Res., 2007, 36(suppl_1), D637-D640.
[97]
Kerrien, S.; Alam-Faruque, Y.; Aranda, B.; Bancarz, I.; Bridge, A.; Derow, C.; Dimmer, E.; Feuermann, M.; Friedrichsen, A.; Huntley, R. IntAct—open source resource for molecular interaction data. Nucleic Acids Res., 2006, 35(suppl_1), D561-D565.
[98]
Keseler, I. M.; Collado-Vides, J.; Gama-Castro, S.; Ingraham, J.; Paley, S.; Paulsen, I. T.; Peralta-Gil, M.; Karp, P. D. EcoCyc: a comprehensive database resource for Escherichia coli. Nucleic Acids Res., 2005, 33(suppl_1), D334-D337.
[101]
Galperin, M. Y.; Cochrane, G. R. Nucleic acids research annual
database issue and the NAR online molecular biology database
collection in 2009. Nucleic Acids Res., 2008, 37(suppl_1), D1-D4.
[114]
Benjamini, Y.; Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc., 1995, 57(1), 289-300.
[132]
Rubin, M.; Shin, D.; Pasmantier, M.; Falcey, J.; Paulter, V.; Fetzer, K.; Waksal, H.; Mendelsohn, J.; Hong, W. Monoclonal antibody (MoAb) IMC-C225, an anti-epidermal growth factor receptor (EGFR), for patients (pts) with EGFR-positive tumors refractory to or in relapse from previous therapeutic regimens. Proc. Am. Soc. Clin. Oncol., 2000, 19, 1860.
[137]
Recombinant humanized anti-HER2 antibody (HerceptinTM) enhances the antitumor activity of paclitaxel and doxorubicin against HER2/neuoverexpressing human breast cancer xenografts. Cancer Res., 1998, 58, 2825-2831.
[140]
Saltz, L. Cetyxunab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11-refractory colorectal cancer (CRC) that express epidermal growth factor receptor (EGFR). Proc. Am. Soc. Clin. Oncol., 2001, 20, 3a.
[143]
Franklin, W.A. Epidermal growth factor receptor family in lung cancer and premalignancy. Semin. Oncol., 2002, 29(1)(Suppl. 4), 3-14.
[146]
Raben, D.; Helfrich, B.; Chan, D.; Kee, A.; Zhao, T. C225 anti-EGFR antibody potentiates radiation (RT) and chemotherapy (CT) cytotoxicity in human non-small cell lung cancer (NSCLC) cells in vitro and in vivo. Proc. Am. Soc. Clin. Oncol., 2001, 257a.
[148]
Hecht, J.; Patnaik, A.; Malik, I.; Venook, A.; Berlin, J.; Croghan, G.; Wiens, B.; Visonneau, S.; Jerian, S.; Meropol, N. ABX-EGF
monotherapy in patients (pts) with metastatic colorectal cancer
(mCRC): an updated analysis. J. Clin. Oncol., 2004, 22(14_suppl), 3511-3511.
[149]
Lynch, D.H. Yang, X.-D. Therapeutic potential of ABX-EGF: a fully human anti-epidermal growth factor receptor monoclonal antibody for cancer treatment. Semin. Oncol., 2002, 29(1)(Suppl. 4), 47-50.
[172]
Zinner, R.; Nemunaitis, J.; Donato, N.; Shin, H.; Myers, J.; Zhang, P.; Zentgraft, R.; Lee, J.; Khuri, F.; Glisson, B. A phase 1 clinical
and biomarker study of the novel pan-erbB tyrosine kinase
inhibitor, CI-1033, in patients with solid tumors. In: Clin. Cancer
Res; AMER ASSOC CANCER RESEARCH PO BOX 11806,
BIRMINGHAM, AL 35202 USA . , 2001, pp. 3767S-3768S.
[173]
Lawrence, T.S.; Nyati, M.K. Small-molecule tyrosine kinase inhibitors as radiosensitizers. Semin. Radiat. Oncol., 2002, 12(3)(Suppl. 2), 33-36.